in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
GSK Acquires Chemical Proteomics Company
1:13 AM MDT | May 16, 2012 | Deepti Ramesh
GlaxoSmithKline (GSK; London) says it has entered into an agreement to acquire those shares it does not currently own in privately held Cellzome (Heidelberg, Germany), a leader in the development and advancement of proteomics technologies, for £61 million ($97 million) in cash. The acquisition is expected to be completed on May 21, 2012. GSK, which currently owns a 19.98% equity interest in Cellzome, will assume full control of the company. Cellzome has laboratories at Cambridge, U.K.; and Heidelberg, and it will become part of GSK’s research &...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee